OTCMKTS:INNV - InnovAge Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $29.80
  • Forecasted Upside: 20.21 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$24.79
▲ +0.03 (0.12%)
1 month | 3 months | 12 months
Get New InnovAge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INNV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INNV

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$29.80
▲ +20.21% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for InnovAge in the last 3 months. The average price target is $29.80, with a high forecast of $32.00 and a low forecast of $26.00. The average price target represents a 20.21% upside from the last price of $24.79.
Buy
The current consensus among 6 investment analysts is to buy stock in InnovAge.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
3/29/2021CitigroupInitiated CoverageBuy$30.00
i
3/29/2021William BlairInitiated CoverageOutperform
i
3/29/2021BarclaysInitiated CoverageEqual Weight$26.00
i
3/29/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$30.00
i
3/29/2021Piper SandlerInitiated CoverageOverweight$31.00
i
3/29/2021The Goldman Sachs GroupInitiated CoverageBuy$32.00
i
11/15/2019HC WainwrightReiterated RatingBuy$5.00
i
Rating by Vernon Bernardino at HC Wainwright
9/17/2019HC WainwrightReiterated RatingBuy$5.00
i
Rating by V. Bernardino at HC Wainwright
5/21/2019HC WainwrightInitiated CoverageBuy
i
Rating by V. Bernardino at HC Wainwright
(Data available from 4/17/2016 forward)
InnovAge logo
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, dental, mental health and psychiatric, meals, and activities, as well as physical, occupational, and speech therapy; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,600 PACE participants in the United States of America; and operates seventeen PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $24.79
$24.42
$25.07

50 Day Range

MA: $21.34
$1.23
$26.04

52 Week Range

Now: $24.79
$20.86
$27.18

Volume

37,950 shs

Average Volume

321,268 shs

Market Capitalization

$3.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Frequently Asked Questions

What sell-side analysts currently cover shares of InnovAge?

The following equities research analysts have issued stock ratings on InnovAge in the last twelve months: Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Piper Sandler, The Goldman Sachs Group, Inc., and William Blair.
View the latest analyst ratings for INNV.

What is the current price target for InnovAge?

5 Wall Street analysts have set twelve-month price targets for InnovAge in the last year. Their average twelve-month price target is $29.80, suggesting a possible upside of 20.2%. The Goldman Sachs Group, Inc. has the highest price target set, predicting INNV will reach $32.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $26.00 for InnovAge in the next year.
View the latest price targets for INNV.

What is the current consensus analyst rating for InnovAge?

InnovAge currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe INNV will outperform the market and that investors should add to their positions of InnovAge.
View the latest ratings for INNV.

What other companies compete with InnovAge?

How do I contact InnovAge's investor relations team?

InnovAge's physical mailing address is 8845 Rehco Road, San Diego CA, 92121. The company's listed phone number is 858-964-5123 and its investor relations email address is [email protected] The official website for InnovAge is www.innovuspharma.com.